Cleveland Clinic, Mount Sinai and Providence won’t give Biogen’s new Alzheimer’s drug
July 16, 2021 at 10:00 AM EDT
Three large hospitals are declining to administer Biogen Inc.’s new Alzheimer’s treatment, Aduhelm, the latest rupture to emerge from the Food and Drug Administration’s controversial approval of the drug last month.
